The pharmaceutical segment led growth, generating Rs. 337 crore in revenue, while the crop protection business contributed Rs. 157 crore
The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
The milestone means more than 1,000 men are now enrolled across both Phase 3 programs
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
The company has commissioned a new plant at Khanna (Punjab), which has begun commercial production
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
The unveiling marks Time Medical India’s entry into next-generation helium-free MRI technology
The board highlighted ongoing investments in Radiopharma, CDMO Sterile Injectables, and CRDMO businesses
The therapy is currently completing Phase 1 clinical trials in renal cell carcinoma and non-small cell lung cancer
The PRIOH-1 study met its primary endpoint, delivering statistically significant and clinically meaningful improvements in lesion healing
Subscribe To Our Newsletter & Stay Updated
